CD8A and neoplasm: [22] In order to activate STING and produce Type I IFN, which in turn restores the CD8+ T cell-dependent immune response in tumor-bearing mice, Falahat R employed DNA methylation inhibitors to reverse the methylation silent of STING in mouse melanoma cells [23].